In conclusion, our findings indicate that RHAMM deletion attenuates obesity-induced TSH elevation, reduces hepatic oxidative stress, and modulates key metabolic signaling pathways in male mice. Here, HMMR is linked to obesity due to melanocortin 4 receptor deficiency.